COVID Vaccine Stocks: The Hares Have Won, But Watch the Tortoises

1 min read

Moderna (NASDAQ: MRNA), Pfizer (NYSE: PFE), and BioNTech (NASDAQ: BNTX) have commanded coronavirus headlines since their vaccines earned Emergency Use Authorization earlier this month. But there are still other vaccine candidates working their way through clinical trials. Dr. Bruce Gellin of the Sabin Vaccine Institute joined Olivia Zitkus and Corinne Cardina of the Fool.com Healthcare and Cannabis Bureau on a Dec. 18 episode of Fool Live to talk about the tortoises of the race and what could give them an edge over the hares.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Could a Universal Social Security Benefit Actually Work?

Next Story

Saving an Extra $100 a Month in Your Retirement Plan Could Leave You This Much Richer

Latest from Blog